HEADER TRANSCRIPTION 13-MAR-07 2P4Y TITLE CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA-LIGAND BINDING DOMAIN TITLE 2 COMPLEXED WITH AN INDOLE-BASED MODULATOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN (LBD), RESIDUES 231-505; COMPND 5 SYNONYM: PPAR-GAMMA; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX4T2 KEYWDS NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, LBD, ALPHA HELIX KEYWDS 2 SANDWICH, PPAR-HOMODIMER, SPPARGM, PARTIAL AGONIST, KEYWDS 3 TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR B.M.MCKEEVER REVDAT 2 24-FEB-09 2P4Y 1 VERSN REVDAT 1 08-JAN-08 2P4Y 0 JRNL AUTH M.EINSTEIN,T.E.AKIYAMA,G.A.CASTRIOTA,C.F.WANG, JRNL AUTH 2 B.MCKEEVER,R.T.MOSLEY,J.W.BECKER,D.E.MOLLER, JRNL AUTH 3 P.T.MEINKE,H.B.WOOD,J.P.BERGER JRNL TITL THE DIFFERENTIAL INTERACTIONS OF PEROXISOME JRNL TITL 2 PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGANDS WITH JRNL TITL 3 TYR473 IS A PHYSICAL BASIS FOR THEIR UNIQUE JRNL TITL 4 BIOLOGICAL ACTIVITIES. JRNL REF MOL.PHARMACOL. V. 73 62 2008 JRNL REFN ISSN 0026-895X JRNL PMID 17940191 JRNL DOI 10.1124/MOL.107.041202 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 169416.600 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 28327 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1402 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 28327 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.39 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3890 REMARK 3 BIN R VALUE (WORKING SET) : 0.3240 REMARK 3 BIN FREE R VALUE : 0.3830 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 210 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.026 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3792 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 93 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.41000 REMARK 3 B22 (A**2) : 9.36000 REMARK 3 B33 (A**2) : -0.95000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.34000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.42 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 0.90 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.66 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.450 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.300 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.230 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.370 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 45.47 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P REMARK 3 PARAMETER FILE 2 : WATER_REP.PAR REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : TRI.PAR REMARK 3 PARAMETER FILE 5 : C02.PAR REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : TRI.TOP REMARK 3 TOPOLOGY FILE 5 : C02.TOP REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: MAXIMUM LIKELIHOOD FUNCTION BASED ON REMARK 3 F REMARK 4 REMARK 4 2P4Y COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-APR-07. REMARK 100 THE RCSB ID CODE IS RCSB041971. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-APR-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29681 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 40.340 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.35330 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.510 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX 2005 REMARK 200 STARTING MODEL: SE-MET PPAR-GAMMA-LBD COMPLEX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.95M TRISODIUM CITRATE, 0.1M TRIS- REMARK 280 HCL PH 8.5, 1MM TCEP, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.07400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.92950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.07400 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 29.92950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAINS. SEE REMARK 350 FOR INFORMATION REMARK 300 ON GENERATING THE BIOLOGICAL MOLECULE. REMARK 300 AUTHORS STATE THAT A PPARGAMMA HOMODIMER IS AN ARTIFACT OF REMARK 300 CRYSTALLIZATION WHICH MAY SERVE AS A MODEL FOR AN ASSEMBLY REMARK 300 OF THE BIOLOGICALLY IMPORTANT HETERODIMER PPAR-RXR. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 201 REMARK 465 SER A 202 REMARK 465 GLN A 203 REMARK 465 LEU A 204 REMARK 465 GLY A 239 REMARK 465 LYS A 240 REMARK 465 THR A 241 REMARK 465 THR A 242 REMARK 465 ASP A 243 REMARK 465 LEU A 255 REMARK 465 MET A 256 REMARK 465 MET A 257 REMARK 465 GLY A 258 REMARK 465 GLU A 259 REMARK 465 ASP A 260 REMARK 465 LYS A 261 REMARK 465 ILE A 262 REMARK 465 LYS A 263 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 465 LYS A 275 REMARK 465 GLU A 276 REMARK 465 VAL A 277 REMARK 465 ALA A 278 REMARK 465 GLY B 201 REMARK 465 SER B 202 REMARK 465 GLN B 203 REMARK 465 LEU B 204 REMARK 465 ASN B 205 REMARK 465 PRO B 206 REMARK 465 GLU B 207 REMARK 465 SER B 208 REMARK 465 THR B 238 REMARK 465 GLY B 239 REMARK 465 LYS B 240 REMARK 465 THR B 241 REMARK 465 THR B 242 REMARK 465 ASP B 243 REMARK 465 LYS B 244 REMARK 465 LEU B 255 REMARK 465 MET B 256 REMARK 465 MET B 257 REMARK 465 GLY B 258 REMARK 465 GLU B 259 REMARK 465 ASP B 260 REMARK 465 LYS B 261 REMARK 465 ILE B 262 REMARK 465 LYS B 263 REMARK 465 PHE B 264 REMARK 465 LYS B 265 REMARK 465 HIS B 266 REMARK 465 ILE B 267 REMARK 465 THR B 268 REMARK 465 PRO B 269 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 LYS B 275 REMARK 465 GLU B 276 REMARK 465 VAL B 277 REMARK 465 GLN B 454 REMARK 465 VAL B 455 REMARK 465 ILE B 456 REMARK 465 LYS B 457 REMARK 465 LYS B 458 REMARK 465 THR B 459 REMARK 465 GLU B 460 REMARK 465 THR B 461 REMARK 465 ASP B 462 REMARK 465 MET B 463 REMARK 465 SER B 464 REMARK 465 LEU B 465 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 253 99.99 -59.37 REMARK 500 LYS A 358 -156.73 53.02 REMARK 500 THR A 461 0.91 -68.44 REMARK 500 LYS A 474 -70.33 -47.86 REMARK 500 ASP A 475 -91.55 -71.77 REMARK 500 LEU A 476 -122.68 70.15 REMARK 500 TYR B 473 40.37 -105.88 REMARK 500 ASP B 475 -73.27 80.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C03 A 478 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C03 B 478 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS A 479 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZEO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA LIGAND BINDING DOMAIN REMARK 900 COMPLEXED WITH AN ALPHA-ARYLOXYPHENYLACETIC ACID AGONIST REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS STATE THAT RESIDUES GLY 201 AND SER 202 IN REMARK 999 CHAINS A AND B ARE THE REMNANTS OF A THROMBIN-CLEAVAGE REMARK 999 SITE BETWEEN GLUTATHIONE-S-TRANSFERASE AND PPARGAMMA-LBD. DBREF 2P4Y A 203 477 UNP P37231 PPARG_HUMAN 231 505 DBREF 2P4Y B 203 477 UNP P37231 PPARG_HUMAN 231 505 SEQADV 2P4Y GLY A 201 UNP P37231 EXPRESSION TAG SEQADV 2P4Y SER A 202 UNP P37231 EXPRESSION TAG SEQADV 2P4Y GLY B 201 UNP P37231 EXPRESSION TAG SEQADV 2P4Y SER B 202 UNP P37231 EXPRESSION TAG SEQRES 1 A 277 GLY SER GLN LEU ASN PRO GLU SER ALA ASP LEU ARG ALA SEQRES 2 A 277 LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SER PHE SEQRES 3 A 277 PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU THR GLY SEQRES 4 A 277 LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR ASP MET SEQRES 5 A 277 ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS PHE LYS SEQRES 6 A 277 HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU VAL ALA SEQRES 7 A 277 ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER VAL GLU SEQRES 8 A 277 ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER ILE PRO SEQRES 9 A 277 GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL THR LEU SEQRES 10 A 277 LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR MET LEU SEQRES 11 A 277 ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SER GLU SEQRES 12 A 277 GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SER LEU SEQRES 13 A 277 ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS PHE GLU SEQRES 14 A 277 PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER SEQRES 15 A 277 ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SER GLY SEQRES 16 A 277 ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP SEQRES 17 A 277 ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU SEQRES 18 A 277 LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE ALA LYS SEQRES 19 A 277 LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE VAL THR SEQRES 20 A 277 GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS THR GLU SEQRES 21 A 277 THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU ILE TYR SEQRES 22 A 277 LYS ASP LEU TYR SEQRES 1 B 277 GLY SER GLN LEU ASN PRO GLU SER ALA ASP LEU ARG ALA SEQRES 2 B 277 LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SER PHE SEQRES 3 B 277 PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU THR GLY SEQRES 4 B 277 LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR ASP MET SEQRES 5 B 277 ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS PHE LYS SEQRES 6 B 277 HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU VAL ALA SEQRES 7 B 277 ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER VAL GLU SEQRES 8 B 277 ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER ILE PRO SEQRES 9 B 277 GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL THR LEU SEQRES 10 B 277 LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR MET LEU SEQRES 11 B 277 ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SER GLU SEQRES 12 B 277 GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SER LEU SEQRES 13 B 277 ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS PHE GLU SEQRES 14 B 277 PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER SEQRES 15 B 277 ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SER GLY SEQRES 16 B 277 ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP SEQRES 17 B 277 ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU SEQRES 18 B 277 LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE ALA LYS SEQRES 19 B 277 LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE VAL THR SEQRES 20 B 277 GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS THR GLU SEQRES 21 B 277 THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU ILE TYR SEQRES 22 B 277 LYS ASP LEU TYR HET C03 A 478 40 HET C03 B 478 40 HET TRS A 479 8 HETNAM C03 (2R)-2-(4-CHLORO-3-{[3-(6-METHOXY-1,2-BENZISOXAZOL-3- HETNAM 2 C03 YL)-2-METHYL-6-(TRIFLUOROMETHOXY)-1H-INDOL-1- HETNAM 3 C03 YL]METHYL}PHENOXY)PROPANOIC ACID HETNAM TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL HETSYN TRS TRIS BUFFER FORMUL 3 C03 2(C28 H22 CL F3 N2 O6) FORMUL 5 TRS C4 H12 N O3 1+ FORMUL 6 HOH *93(H2 O) HELIX 1 1 ASN A 205 PHE A 226 1 22 HELIX 2 2 THR A 229 THR A 238 1 10 HELIX 3 3 ILE A 279 LYS A 301 1 23 HELIX 4 4 GLY A 305 LEU A 309 5 5 HELIX 5 5 ASP A 310 SER A 332 1 23 HELIX 6 6 ARG A 350 SER A 355 1 6 HELIX 7 7 ARG A 357 GLY A 361 5 5 HELIX 8 8 MET A 364 ASN A 375 1 12 HELIX 9 9 ALA A 376 GLU A 378 5 3 HELIX 10 10 ASP A 380 LEU A 393 1 14 HELIX 11 11 ASN A 402 HIS A 425 1 24 HELIX 12 12 GLN A 430 GLU A 460 1 31 HELIX 13 13 HIS A 466 ASP A 475 1 10 HELIX 14 14 ALA B 209 PHE B 226 1 18 HELIX 15 15 THR B 229 LEU B 237 1 9 HELIX 16 16 ALA B 278 SER B 302 1 25 HELIX 17 17 GLY B 305 LEU B 309 5 5 HELIX 18 18 ASP B 310 LEU B 333 1 24 HELIX 19 19 ARG B 350 SER B 355 1 6 HELIX 20 20 ARG B 357 ASP B 362 1 6 HELIX 21 21 MET B 364 LEU B 377 1 14 HELIX 22 22 ASP B 380 LEU B 393 1 14 HELIX 23 23 ASN B 402 HIS B 425 1 24 HELIX 24 24 GLN B 430 LEU B 453 1 24 HELIX 25 25 HIS B 466 TYR B 473 1 8 SHEET 1 A 4 PHE A 247 ILE A 249 0 SHEET 2 A 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 A 4 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 4 A 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SHEET 1 B 3 PHE B 247 ILE B 249 0 SHEET 2 B 3 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 B 3 GLY B 338 ILE B 341 -1 N ILE B 341 O GLY B 346 SITE 1 AC1 20 PHE A 226 GLY A 284 CYS A 285 ARG A 288 SITE 2 AC1 20 SER A 289 ALA A 292 ILE A 296 ILE A 326 SITE 3 AC1 20 TYR A 327 MET A 329 LEU A 330 VAL A 339 SITE 4 AC1 20 LEU A 340 ILE A 341 SER A 342 LEU A 353 SITE 5 AC1 20 PHE A 363 MET A 364 HIS A 449 TRS A 479 SITE 1 AC2 18 PHE B 226 CYS B 285 ARG B 288 SER B 289 SITE 2 AC2 18 ALA B 292 ILE B 296 ILE B 326 TYR B 327 SITE 3 AC2 18 MET B 329 LEU B 330 LEU B 333 VAL B 339 SITE 4 AC2 18 LEU B 340 ILE B 341 SER B 342 LEU B 353 SITE 5 AC2 18 MET B 364 HIS B 449 SITE 1 AC3 11 PHE A 282 GLN A 286 SER A 289 HIS A 323 SITE 2 AC3 11 PHE A 363 HIS A 449 LEU A 453 LEU A 465 SITE 3 AC3 11 LEU A 469 TYR A 473 C03 A 478 CRYST1 92.148 59.859 118.287 90.00 103.76 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010852 0.000000 0.002658 0.00000 SCALE2 0.000000 0.016706 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008704 0.00000 MASTER 363 0 3 25 7 0 13 6 0 0 0 44 END